| Code | 4390E | ||||||||||
| MA number | 59/0205/23-S | ||||||||||
| Product Form: | cps end 14x120 mg (blis.Al/PVC/PVDC) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Farmaprojects S.A.U., Spain | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister Al/PVC/PVDC | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 18.10.2023 |
| Validity: | 18.10.2028 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Cohiber_09_2023.pdf
|
| SPC: |
SPC_Cohiber_09_2023.pdf
|
| Safety feature | Yes |
| Data update: | 24.10.2023 |
